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ABSTRACT
Objective: At present, toxicological tests are resource-intensive, time-consuming and require a large pool of animal models for toxicity assessment.
To speed up the toxicity evaluation and to reduce animal suffering during toxicity assessment, the use of alternative methods including computational
models is in high demand. The computational toxicity prediction methods are very helpful for the regulatory bodies to quickly assess the health
impact of nanomaterial materials. In the present work, we have examined the mechanism of zinc oxide nanoparticle (ZnO-NP)-proteins interaction
and their effect of surface chemistries of ZnO-NP on the bioactive conformation of chemokines and other cytological proteins using in silico molecular
docking approaches.
Methods: Molecular docking study was conducted using AutoDock 4.0 version and the visualization result using Discover Studio 4.0.

Results: In the present study, we observed that ZnO-NP has high binding affinity with the mitogen-activated protein kinases (P-38), nuclear
factor kappa-light-chain-enhancer of activated B cell (NF-kB) proteins, and matrix metallopeptidase-9 with docking energies −8.81, −7.64, and
−7.27 Kcal/Mol, respectively, involving with hydrogen, metal acceptor, and electrostatic interaction. The top interacting amino acid residues with
ZnO-NP are GLY, PHE, ARG, ASP, GLN, and ASN.
Conclusion: Thus, based on the molecular docking studies, we determine that the ZnO-NP is strongly interacting with the chemokines and other
cytological proteins thus responsible for blocking of the activation stimuli for these proteins to initiate the biological signals for the proper functioning.
We have also extracted the information of interaction pattern of ZnO-NP with the surface-enriched amino acid residues of chemokine and cytological
proteins using molecular docking approach.
Keywords: Zinc oxide nanoparticle, Molecular docking, Nanoparticle-protein interaction, Toxicity.
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INTRODUCTION
Nanomaterials are of great interest because of their novel properties,
including a large specific surface area and high reaction activity [1,2].
In current scenario, expansion in nanotechnology engineering has
increased the prompt development of many applications for
nanomaterials such as metal nanoparticles (NP) (e.g., gold and silver),
metal oxide NP (e.g., CuO, TiO2, and zinc oxide NP [ZnO]), C60 fullerenes
nanocrystals, and carbon nanotubes (CNTs) [3-6]. In case of NP, the
diverse materials were found, for example, gold, silica, titanium, CNTs,
zinc, and quantum dots have shown unique mechanisms of proteins
modifications, lipid peroxidation, and DNA fragmentation reactive
oxygen species possible that lead to cellular damage and other several
disorders including cancer [7]. ZnO is most widely commonly utilized
as a group of nanomaterials [8]. The progressive utilized ZnO-NPs in
sunscreens, biosensors, food additives, pigments, rubber manufacture,
and electronic materials. Rise concerns have also been its unintentional
health, environmental impacts, and negative effects on the survival
and growth of organisms [9]. A number of in vitro studies proved that
ZnO-NPs are toxic for mammalian cells and are even more toxic than
other nanoscale structures of metallic oxide [10,11]. The interaction of
nanomaterial with proteins results in physiological changes that lead to
various pathological phenotypes. However, the mechanism underlying
these changes remain poorly understood. In this study, we have
selected some of the chemokine and cytological proteins which were
previously suggested to interact with ZnO-NP in various experimental
settings [12-16]. It was experimentally verified that the interaction
of ZnO-NP with ICAM-1, IL8, IL1B, P-38, and nuclear factor (NF-kB)
induces expression of these proteins [12,17-19], similarly in case of

CCL18 and CD35, interaction resulted in decreased expression [14,20].
The matrix metallopeptidase-9 (MMP-9) interacts with ZnO-NP which
results in the increase enzymatic activity [14]. ZnO-NPs get absorbed
systemically in the liver, adipose, and pancreas, which can elevate the
level of zinc in the body [21]. The stimulation of oxidative stress is the
vital part of the cytotoxicity of ZnO-NPs [22]. The major challenge in
the current study is to deal with the size, density, and surface property
variation of the nanomaterial because in the case of in vitro and in vivo
experimental settings, these parameters were either poorly determined
or with very broad range [23]. Furthermore, very few methods and
studies are available where the toxicity of ZnO-NP was assessed using
a computational method. In the case of new materials, computational
toxicity prediction methods are now frequently used by regulatory
bodies to quickly assess the health hazards. In the present study, we have
investigated the mechanism of ZnO-NP-protein interaction and their
effect of surface chemistries of ZnO-NP on the bioactive conformation
of chemokines and other cytological proteins using in silico molecular
docking approaches. We have selected those proteins which have
already reported interaction with ZnO-NP and also well-established
in the earlier works using in vitro techniques, and the in -silico results
have been discussed comparatively. We have specifically investigated
the effect of NP toxicity and an insight into the regularity of interaction
has been attempted between NPs with specific amino acids.
METHODS

Retrieval of chemokine and other cytological proteins threedimensional (3D) conformation
The coordinates of selected proteins (Table 1) were obtained from
the RCSB protein data bank (http://www.rcsb.org/pdb/home/

Singh et al.

home.do). The protein molecules were prepared for the molecular
interaction studies using the prepare protein protocols of Biovia
Discovery Studio 4.0 software suit. Prepared protein protocol fixed
various protein structure errors such as missing atoms in incomplete
residues, missing loop regions, alternate conformations (disorder),
non-standard atom names, and incorrect protonation state of
titratable residues. For molecular docking studies, we defined the
active sites of proteins using in silco literature, [24] and rest of active
site of proteins were retrieved using COACH server [25]. COACH
is a meta-server for the prediction of protein-ligand binding site
prediction. The prediction of the active site is mainly based on two
comparative methods, TM-SITE and S-SITE, which recognize ligandbinding templates from the BioLiP protein function database [25]
by binding-specific substructure and sequence profile comparisons.
The assessment of the active site was done using the confidence
score (C-score) that determined the accuracy of the active site
prediction. C-score ranges 0–1, where a higher score indicates a more
reliable prediction and this score is defined based on the quality of
the threading alignments and the convergence of the I-TASSER’s
structural assembly refinement simulations.
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Where M is the number of structure decoys in the cluster and Mtot is
the total number of decoys generated during the I-TASSER simulations,
RMSD is the average deviation of the decoys from the cluster centroid.
Z(i) is the Z-score of the best template generated by ith threading in
the seven LOMETS programs and Z0(i) is a program-specified Z-score
cutoff for distinguishing between good and bad templates. The actives
site residues of selected chemokine and other cytological proteins are
shown in Fig. 1.
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3D model of ZnO-NP
3D nano-system of ZnO-NP with a dimension of 1 nm was built with
the help of build protocol of Biovia Material Studio 7.0. The NP was
optimized using Forcite geometry optimization protocol [26]. The
geometry optimization was done using COMPASS force field at 1NVT,
300K for 100 ps.

Molecular docking of ZnO-NP with proteins
Molecular docking plays important part in the study the interaction of
ligand with active site residues of the receptor [27]. Molecular docking
of ZnO-NP with the chemokines and other cytological proteins were
performed using the AutoDock4.0 [28,29]. AutoDock has been already
implemented by several researchers to study numerous proteins-NP
interactions [30-32]. Before going for molecular docking, hydrogen
atoms were added to all target proteins. Kollman united charges and
salvation parameters were added to the proteins. Gasteiger charge
was added to the ZnO-NP. Grid box was set in such a manner that it
will cover the active sites of chemokines and cytological proteins so that
the interaction will take place on the active site of proteins. The values
were set to 60 × 60 × 60 3 Å in X, Y, and Z-axis of the grid point. The grid
point spacing was kept at 0.375 Å. Lamarckian Genetic Algorithm [33]
and flexible docking calculations were used for the docking purpose.
ZnO-NP was placed at random starting position random orientation and
torsions were used. For the translation, quaternion and torsion steps
were consider as default values in AutoDock. In AutoDock standard
docking protocol for ligand docking consisted of 10 independent runs
per ligand, considering an initial population of 50 randomly placed
individuals, with 2.5 × 106 energy evaluations, a maximum number of
27,000 iterations, a mutation rate of 0.02, a crossover rate of 0.80, and
an elitism value of 1. The local search for an individual in the population
was 0.06, using a maximum of 300 iterations per local search. After
docking, the 10 solutions were clustered into groups with RMS
deviations lower than 1.0 Å. The clusters were ranked by the lowest
energy representative of each cluster. Discovery Studio 4.0 was used to
analyze the resultant conformations for the intermolecular interactions
and binding energy.
Investigate the consequence of the interaction of ZnO-NP on
biological processes
After molecular docking study, it is important to understand the
biological processes in which these proteins were plays important role.
We can comprehensive understand and actual impact of the docking
in the biological system. To understand the biological impact, we
have retrieved all the biological function of the proteins which were
taken in the study in a form of network that interacts to accomplish
a process to the level with in the cell or organism. Different biological
functions of chemokines and other cytological proteins were accessed
using PANTHER (http://pantherdb.org) (protein analysis through
evolutionary relationships). Classification system was designed to
classify proteins (and their genes) to facilitate high-throughput analysis.
RESULTS AND DISCUSSION

e
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Fig. 1: Interaction of zinc oxide nanoparticle with the activation
site cavity of Chemokines and other cytological proteins.
(a) p-38 protein, (b) nuclear factor-kB protein, (c) matrix
metallopeptidase-9 protein, (d) IL-1B protein, (e) CCL-18 protein,
(f) IL8 protein, (g) ICAM-1 protein, (h) CD-35 protein, respectively

In this study, we have taken cellular proteins into consideration for the
examination of their interactions with ZnO-NP and the possible functions
that can affect the physiology. All the putative targets of ZnO-NP and the
active site predictions were carried out using COACH meta-server. The
best active sites prediction base on the C-score of COACH meta-server
for IL-1B and CCL-18 proteins are 0.23 and 0.26. In our docking studies,
we have defined the active site of proteins to perform control docking
with ZnO-NP. The best docking poses of ZnO-NP with proteins based on
AutoDock binding energy were analyzed further. The best docking energy
of ZnO-NP with P-38 (−8.81 Kcal/Mol), a total of 4 hydrogen bonds with
GLY202, GLU203, ILE204, VAL369 and 4 electrostatic bonds formed
with APS43, GLU203, ASP370, PHE371, and also 2 Metal Acceptor bonds
with ASP365 and VAL369 amino acid residues which clearly indicate
that the ZnO-NP strongly bind to the active site cavity. We observed the
secondbest docking energy (−7.64 Kcal/Mol) of ZnO-NP with NF-kB
protein, it forms 5 hydrogen bonds with ARG57, HIS67, GLY68, PRO71,
442
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Fig. 2: Illustration of the interaction network of zinc oxide nanoparticle (ZnO-NP) with chemokines and other cytological proteins. Nodes
with different colors represent various Biological functions of proteins which were inhibited by ZnO-NP. The figure legend represents the
function of these proteins
Table 1: Docking energies and bond information of ZnO‑NP with chemokines and other cytological proteins
Proteins

NP

Energy in (Kcal/Mol)

Total number of H Bond

Metal acceptor

1I1B (IL‑1B)
1GKG (CD 35)
1L6J (MMP‑9)
1IL8 (IL8)
4MHE (CCL‑18)
1P53 (ICAM‑1)
1SVC (NF‑kB)
3W8Q (P‑38)

ZnO‑NP

−3.23
−3.92
−7.27
−5.14
−3.13
−4.95
−7.64
−8.81

3
2
5
2
3
2
5
4

‑
1
2
2
4
1
3
2

and SER243, 3 metal acceptor bonds with GLY55, ARG57, and HIS67 and
1 electrostatic bond with PHE56 amino acid residues, and it also has
strong binding in the active site cavity. On the other side, we observed
least binding affinity for ZnO-NP with CCL-18 (−3.13 Kcal/Mol), whereas
it forms only 3 hydrogen bonds and 4 metal acceptors with GLY5, ASN7,
and GLN34 amino acid residues. The binding energies of other proteins,
namely, ICAM-1, IL8, MMP-9, IL-1B, and CD-35 proteins with ZnO-NP are
listed in Table 1.
From the molecular docking interactions, we have extracted the key
residues of proteins which play important role in the binding of ZnONP more efficiently GLY which is hydrophobic in nature and present
in 1SVC, 3W8Q, 1I6J, and 1I1B proteins. The rest of key residues
interacting with proteins are PHE, ARG, ASP, GLN, and ASN and their
nature were given in Table 2.

The amino acids show least interaction with ZnO-NP is LYS, VAL,
THR, TYR, TRP, and LEU. Details of molecular interactions of ZnONP with chemokines and other cytological proteins are provided
in Supplementary Table 1 and the best interacting pose was shown
in Fig. 1. The molecular docked proteins have a specific role in
biological processes which can affect by the interaction with ZnONP. The outcome from this study clearly indicated that the ZnO-NP
inhibits the process of response to a stimulus, cellular process, and
biological adhesion more effectively and other processes were given
in Fig. 2.

Electrostatic
Pi‑Cation

Attractive charge

‑
1
1
‑
‑
‑
1
1

3
‑
1
1
‑
2
‑
3

Fig. 2: Illustration of the interaction network of zinc oxide nanoparticle
(ZnO-NP) with chemokines and other cytological proteins. Nodes with
different colors represent various Biological functions of proteins which
were inhibited by ZnO-NP. The figure legend represents the function of
these proteins

Protein ICAM-1 also known as CD54 (cluster of differentiation
54) has an important role in cell-cell signaling for stabilization
of cell-cell interaction and facilitates the leukocyte endothelial
transmigration [34,35]. The ICAM-1 plays a significant role in
spermatogenesis due to its antagonistic effect on the tight junctions
forming the blood test is barrier [34]. P-38 has an important function
in cell-cell signaling against stress and is responsive to stress
stimuli, such as cytokines, ultraviolet irradiation, heat shock, and
osmotic shock. It is also involved in cell differentiation, apoptosis,
and autophagy [36,37]. Similarly, NF-kB plays a very important role
in several cellular functions. NF-kB controls the cellular responses
as it belongs to the category of “rapid-acting” primary transcription
factor, i.e., a transcription factor which was present in cells in an
inactive state and does not undergo new protein synthesis to become
activated [38,39]. Several innate and adaptive immune response genes
are regulated by a transcription factor (NF-kB) [40-42]. Interaction of
ZnO-NP with proteins might be altering the functional properties, as
results may affect stabilization of cell-cell interactions. It is a newer
approach to determine the ZnO-NP interaction with proteins using
docking, without any surface modification of NP.
443
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Table 2: Complete H‑bond interaction analysis of amino acid residues of proteins with ZnO‑NP
Amino
acids
residues

1SVC

3W8Q

1I6J

1IL8

1GKG

1P53

1I1B

4MHE

Charged (side
chains often
make salt
bridges)

Polar (usually
participate in
hydrogen bonds
as proton donors
or acceptors)

Hydrophobic (normally
buried inside the
protein core)

PHE
ARG
GLY
HIS
PRO
SER
GLN
LYS
ILE
VAL
ASP
GLU
THR
ASN
TYR
TRP
LEU







‑
‑
‑
‑
‑
‑
‑
‑
‑
‑
‑


‑

‑
‑
‑
‑
‑
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‑
‑
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‑
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‑
‑
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‑

‑
‑
‑



‑
‑
‑
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‑
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‑
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‑

‑
‑
‑
‑
‑
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‑
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‑
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‑
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‑
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‑

‑
‑
‑


‑
‑
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‑
‑

Thesign indicates that the particular H‑bond is present while ‑ indicates its absence and also the nature of interacting amino acid residues, ZnO‑NP: Zinc oxide
nanoparticle

CONCLUSION

5.

Using molecular docking as computational approaches could be
adopted for the screening of all the NPs, which can bind to the target
with experimental or modeled structures. A number of studies
already reported that engineer NP particles (ENPs) interact with the
biological macromolecules. Recent studies have shown that ENPs
inhibit enzyme activity due to their interaction with the active site or
binding directly with the substrate [43,44]. Using molecular docking
studies, we conclude that the ZnO-NP is strongly interacting with the
chemokines and other cytological proteins on its activation site and
thus responsible for blocking of the activation stimuli for chemokines,
and other cytological proteins to initiate the biological signals for
the proper functioning of these proteins . In contrast, from the above
results, it indicates the key interacting amino acid residues with ZnONP and their nature. Which plays important role in the interaction of
ZnO-NP with proteins.
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Supplementary Table 1: Detail interaction of ZnO‑NP with chemokines and other cytological proteins
Residues

Distance

Category

Type

ZnO: Zn‑P‑38:GLU203:OE2
ZnO: Zn‑P‑38:ASP370:OD1
ZnO: Zn‑P‑38:ASP43:OD1
ZnO: O‑P‑38:ILE204:HN
ZnO: O‑P‑38:VAL369:HN
ZnO: O‑P‑38:GLY202:O
ZnO: O‑P‑38:GLU203:CA
ZnO: Zn‑P‑38:VAL369:O
ZnO: Zn‑P‑38:ASP365:O
ZnO: Zn‑P‑38:PHE371
ZnO: O‑NF‑kB: ARG57:HH12
ZnO: O‑NF‑kB: HIS67:HD1
ZnO: O‑NF‑kB: SER243:HG
ZnO: O‑NF‑kB: GLY68:CA
ZnO: O‑NF‑kB: PRO71:CD
ZnO: Zn‑NF‑kB: GLY55:O
ZnO: Zn‑NF‑kB: HIS67:O
ZnO: Zn‑NF‑kB: ARG57:O
ZnO: Zn‑NF‑kB: PHE56
ZnO: Zn‑ICAM‑1: GLU425:OE2
ZnO: Zn‑ICAM‑1:GLU425:OE2
ZnO: O‑ICAM‑1:TRP380:HN
ZnO: O‑ICAM‑1:ASN446:O
ZnO: Zn‑ICAM‑1:ASN446:O
ZnO: O‑CCL18:ASN7:HD22
ZnO: O‑CCL18:GLN34:HE22
ZnO: O‑CCL18:GLY5:O
ZnO: Zn‑CCL18:ASN7:OD1
ZnO: Zn‑CCL18:GLY5:O
ZnO: Zn‑CCL18:GLN34:O
ZnO: Zn‑MMP‑9:ASP185:OD1
ZnO: O‑MMP‑9:GLN391:HN
ZnO: O‑MMP‑9:GLY213:O
ZnO: O‑MMP‑9:TYR423:OH
ZnO: O‑MMP‑9:ASP390:OD2
ZnO: O‑MMP‑9:ARG424:CA
ZnO: Zn‑MMP‑9:GLY392:O
ZnO: Zn‑MMP‑9:PHE425:O
ZnO: Zn‑MMP‑9:TYR393
ZnO: O‑IL8:ASN56:HD22
ZnO: O‑IL8:ARG60:HH21
ZnO: Zn‑IL8:ASN56:O
ZnO: Zn‑IL8:GLN59:OE1
ZnO: O‑CD35: HIS1012:HD2
ZnO: O‑CD35: PRO1017:HD2
ZnO: Zn‑CD35: THR1015:O
ZnO: Zn‑CD35: HIS1012
ZnO: Zn‑IL1B: ASP76:OD1
ZnO: Zn‑IL1B: ASP76:OD1
Zn0: Zn‑IL1B: ASP76:OD1
ZnO: O‑IL1B: LEU73:HN
ZnO: O‑IL1B: ASP75:HN
ZnO: O‑IL1B: LYS74:CA

4.06365
5.59144
4.21727
2.25282
2.10758
3.32089
2.88581
2.88454
2.9422
4.97511
2.23276
2.87536
1.88466
2.82779
3.2695
2.04267
1.8762
2.67725
2.96504
4.49948
4.83506
2.57444
3.17571
3.3466
2.02907
2.3415
2.60665
1.96232
2.53086
2.40398
4.16553
2.28783
3.06005
2.92205
3.18349
2.614
2.4448
2.19957
4.06398
2.09676
2.35651
2.28737
1.77352
2.17824
1.9715
2.35972
2.08723
5.15809
5.07859
5.46359
0.465623
2.70242
1.48856

Electrostatic
Electrostatic
Electrostatic
Hydrogen bond
Hydrogen bond
Hydrogen bond
Hydrogen bond
Other
Other
Electrostatic
Hydrogen bond
Hydrogen bond
Hydrogen bond
Hydrogen bond
Hydrogen bond
Other
Other
Other
Electrostatic
Electrostatic
Electrostatic
Hydrogen bond
Hydrogen bond
Other
Hydrogen bond
Hydrogen bond
Hydrogen bond
Other
Other
Other
Electrostatic
Hydrogen bond
Hydrogen bond
Hydrogen bond
Hydrogen bond
Hydrogen bond
Other
Other
Electrostatic
Hydrogen bond
Hydrogen bond
Other
Other
Hydrogen bond
Hydrogen bond
Other
Electrostatic
Electrostatic
Electrostatic
Electrostatic
Hydrogen bond
Hydrogen bond
Hydrogen bond

Attractive charge
Attractive charge
Attractive charge
Conventional hydrogen bond
Conventional hydrogen bond
Conventional hydrogen bond
Carbon‑hydrogen bond
Metal acceptor
Metal acceptor
Pi‑cation
Conventional hydrogen bond
Conventional hydrogen bond
Conventional hydrogen bond
Carbon‑hydrogen bond
Carbon‑hydrogen bond
Metal acceptor
Metal acceptor
Metal acceptor
Pi‑cation
Attractive charge
Attractive charge
Conventional hydrogen bond
Conventional hydrogen bond
Metal‑acceptor
Conventional hydrogen bond
Conventional hydrogen bond
Conventional hydrogen bond
Metal acceptor
Metal acceptor
Metal acceptor
Attractive charge
Conventional hydrogen bond
Conventional hydrogen bond
Conventional hydrogen bond
Conventional hydrogen bond
Carbon‑hydrogen bond
Metal acceptor
Metal acceptor
Pi‑cation
Conventional hydrogen bond
Conventional hydrogen bond
Metal acceptor
Metal acceptor
Carbon‑hydrogen bond
Carbon‑hydrogen bond
Metal acceptor
Pi‑cation
Attractive charge
Attractive charge
Attractive charge
Conventional hydrogen bond
Conventional hydrogen bond
Carbon‑hydrogen bond
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